Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review

References

• Global Asthma Network. The global asthma report; 2014 Available from: http://www.globalasthmareport.org/2014/index.php. Accessed 117, 2019.
   Google Scholar
• World Health Organization. Chronic obstructive pulmonary disease (COPD) fact sheet; 2015 Available from: http://www.who.int/mediacentre/factsheets/fs315/en/. Accessed 117, 2019.
   Google Scholar
• NurmagambetovT, KuwaharaR, GarbeP. The economic burden of asthma in the United States, 2008–2013. Ann Am Thorac Soc. 2018;15(3):348–356. doi:10.1513/AnnalsATS.201703-259OC29323930
   PubMed Web of Science ®Google Scholar
• GuarascioAJ, RaySM, FinchCK, SelfTH. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res. 2013;5:235–245. doi:10.2147/CEOR.S3432123818799
   PubMedGoogle Scholar
• PatelJG, NagarSP, DalalAA. Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States. Int J Chron Obstruct Pulmon Dis. 2014;9:289–300. doi:10.2147/COPD.S5715724672234
   PubMed Web of Science ®Google Scholar
• SvedsaterH, RobertsJ, PatelC, MaceyJ, HiltonE, BradshawL. Life impact and treatment preferences of individuals with asthma and chronic obstructive pulmonary disease: results from qualitative interviews and focus groups. Adv Ther. 2017;34(6):1466–1481. doi:10.1007/s12325-017-0557-028536998
   PubMed Web of Science ®Google Scholar
• US Dept of Health and Human Services National Heart, Lung and Blood Institute (NHLBI). Guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention Program Expert Panel Report 3, Summary Report; 10 2017 NIH Publication Number 08-5846.
   Google Scholar
• VestboJ, HurdSS, AgustiAG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP22878278
   PubMed Web of Science ®Google Scholar
• MelaniAS, BonaviaM, CilentiV, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105(6):930–938. doi:10.1016/j.rmed.2011.01.00521367593
   PubMed Web of Science ®Google Scholar
• PressVG, AroraVM, ShahLM, et al. Misuse of respiratory inhalers in hospitalized patients with asthma or COPD. J Gen Intern Med. 2011;26(6):635–642. doi:10.1007/s11606-010-1624-221249463
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease; 2019 Available from: https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf. Accessed 117, 2019.
   Google Scholar
• CazzolaM, MateraMG. Fixed-dose combination inhalers. Handb Exp Pharmacol. 2017;237:117–129.27783268
   PubMedGoogle Scholar
• ChantaphakulH, RuxrungthamK. Fixed-dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma. Expert Opin Pharmacother. 2016;17(5):631–642. doi:10.1517/14656566.2016.114565926799114
   PubMed Web of Science ®Google Scholar
• RodrigoGJ, NeffenH. A systematic review of the efficacy and safety of a fixed-dose combination of umeclidinium and vilanterol for the treatment of COPD. Chest. 2015;148(2):397–407. doi:10.1378/chest.15-008425798635
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Developing NICE guidelines: the manual [Appendix H]. London; 2015 Available from: https://www.nice.org.uk/process/pmg20/resources/appendix-h-pdf-2549710190. Accessed 117, 2019.
   Google Scholar
• HusereauD, DrummondM, PetrouS, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Value Health. 2013;16(2):e1–e5. doi:10.1016/j.jval.2013.02.01023538200
   PubMed Web of Science ®Google Scholar
• StempelDA, StoloffSW, Carranza RosenzweigJR, StanfordRH, RyskinaKL, LegorretaAP. Adherence to asthma controller medication regimens. Respir Med. 2005;99(10):1263–1267. doi:10.1016/j.rmed.2005.03.00216140227
   PubMed Web of Science ®Google Scholar
• StoloffSW, StempelDA, MeyerJ, StanfordRH, Carranza RosenzweigJR. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol. 2004;113(2):245–251. doi:10.1016/j.jaci.2003.10.01114767437
   PubMed Web of Science ®Google Scholar
• MarceauC, LemiereC, BerbicheD, PerreaultS, BlaisL. Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma. J Allergy Clin Immunol. 2006;118(3):574–581. doi:10.1016/j.jaci.2006.06.03416950273
   PubMed Web of Science ®Google Scholar
• ElkoutH, HelmsPJ, SimpsonCR, McLayJS. Adequate levels of adherence with controller medication is associated with increased use of rescue medication in asthmatic children. PLoS One. 2012;7(6):e39130. doi:10.1371/journal.pone.003913022761728
   PubMed Web of Science ®Google Scholar
• ChanJ, HuiRL, SpenceMM. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids. J Manag Care Pharm. 2007;13(1):21–27.
   PubMed Web of Science ®Google Scholar
• RosenhallL, BorgS, AnderssonF, EricssonK. Budesonide/formoterol in a single inhaler (Symbicort) reduces healthcare costs compared with separate inhalers in the treatment of asthma over 12 months. Int J Clin Pract. 2003;57(8):662–667.14627174
   PubMed Web of Science ®Google Scholar
• O’ConnorRD, RosenzweigJR, StanfordRH, et al. Asthma-related exacerbations, therapy switching, and therapy discontinuation: a comparison of 3 commonly used controller regimens. Ann Allergy Asthma Immunol. 2005;95(6):535–540. doi:10.1016/S1081-1206(10)61015-016400892
   PubMed Web of Science ®Google Scholar
• LatryP, PinetM, LabatA, et al. Adherence to anti-inflammatory treatment for asthma in clinical practice in France. Clin Ther. 2008;30(Spec No):1058–1068. doi:10.1016/j.clinthera.2008.06.01118640480
   PubMed Web of Science ®Google Scholar
• AubierM, PietersWR, SchlosserNJ, SteinmetzKO. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (seretide) is effective and safe in the treatment of steroid-dependent asthma. Respir Med. 1999;93(12):876–884. doi:10.1016/S0954-6111(99)90053-710653049
   PubMed Web of Science ®Google Scholar
• PerrinK, WilliamsM, WijesingheM, JamesK, WeatherallM, BeasleyR. Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting beta-agonist inhaler therapy in asthma. J Allergy Clin Immunol. 2010;126(3):505–510. doi:10.1016/j.jaci.2010.06.03320816187
   PubMed Web of Science ®Google Scholar
• ZetterstromO, BuhlR, MellemH, et al. Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone. Eur Respir J. 2001;18(2):262–268. doi:10.1183/09031936.01.0006580111529282
   PubMed Web of Science ®Google Scholar
• RosenhallL, HeinigJH, LindqvistA, LeegaardJ, StahlE, BergqvistPB. Budesonide/formoterol (Symbicort) is well tolerated and effective in patients with moderate persistent asthma. Int J Clin Pract. 2002;56(6):427–433.12166540
   PubMed Web of Science ®Google Scholar
• ChrischillesE, GildenD, KubisiakJ, RubensteinL, ShahH. Delivery of ipratropium and albuterol combination therapy for chronic obstructive pulmonary disease: effectiveness of a two-in-one inhaler versus separate inhalers. Am J Manag Care. 2002;8(10):902–911.12395958
   PubMed Web of Science ®Google Scholar
• YorkJM, SmeedingJ, BrookRA, HoehlerF, KleinGL. Exploratory economic evaluation of patients with COPD on a combination product versus individual components (ipratropium bromide and albuterol). Adv Ther. 2007;24(4):757–771. doi:10.1007/BF284996917901025
   PubMed Web of Science ®Google Scholar
• HagedornC, KassnerF, BanikN, NtampakasP, FielderK. Influence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPD. Respir Med. 2013;107(4):542–549. doi:10.1016/j.rmed.2012.12.02023337300
   PubMed Web of Science ®Google Scholar
• FergusonGT, GhafouriM, DaiL, DunnLJ. COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study. Int J Chron Obstruct Pulmon Dis. 2013;8:139–150. doi:10.2147/COPD.S3857723658479
   PubMed Web of Science ®Google Scholar
• BrüggenjürgenB, EzzatN, KardosP, BuhlR. Economic evaluation of BDP/formoterol fixed versus two single inhalers in asthma treatment. Allergy. 2010;65(9):1108–1115. doi:10.1111/j.1398-9995.2009.02317.x20121768
   PubMed Web of Science ®Google Scholar
• ElkoutH, McLayJS, SimpsonCR, HelmsPJ. A retrospective observational study comparing rescue medication use in children on combined versus separate long-acting beta-agonists and corticosteroids. Arch Dis Child. 2010;95(10):817–821. doi:10.1136/adc.2009.17906920656730
   PubMed Web of Science ®Google Scholar
• StallbergB, EkstromT, NeijF, et al. A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma. Respir Med. 2008;102(10):1360–1370. doi:10.1016/j.rmed.2008.06.01718723335
   PubMed Web of Science ®Google Scholar
• ChervinskyP, BakerJ, BenschG, et al. Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler. Ann Allergy Asthma Immunol. 2008;101(5):463–473. doi:10.1016/S1081-1206(10)60284-019055199
   PubMed Web of Science ®Google Scholar
• RosenhallL, ElvstrandA, TillingB, et al. One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort Turbuhaler) for the treatment of asthma. Respir Med. 2003;97(6):702–708. doi:10.1053/rmed.2003.150412814158
   PubMed Web of Science ®Google Scholar
• YuAP, GuerinA, de LeonDP, et al. Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD. Respir Med. 2011;105(12):1861–1871. doi:10.1016/j.rmed.2011.07.00121807487
   PubMed Web of Science ®Google Scholar
• BenayounS, ErnstP, SuissaS. The impact of combined inhaled bronchodilator therapy in the treatment of COPD. Chest. 2001;119(1):85–92. doi:10.1378/chest.119.1.8511157588
   PubMed Web of Science ®Google Scholar
• DahlR, JadayelD, AlagappanVK, ChenH, BanerjiD. Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study. Int J Chron Obstruct Pulmon Dis. 2013;8:501–508. doi:10.2147/COPD.S4961524159259
   PubMed Web of Science ®Google Scholar
• TashkinDP, RennardSI, MartinP, et al. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial. Drugs. 2008;68(14):1975–2000. doi:10.2165/00003495-200868140-0000418778120
   PubMed Web of Science ®Google Scholar
• Bodzenta-LukaszykA, PulkaG, DymekA, et al. Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler. Respir Med. 2011;105(5):674–682. doi:10.1016/j.rmed.2010.11.01121196104
   PubMed Web of Science ®Google Scholar
• Bodzenta-LukaszykA, van NoordJ, Schroder-BaboW, McAulayK, McIverT. Efficacy and safety profile of fluticasone/formoterol combination therapy compared to its individual components administered concurrently in asthma: a randomised controlled trial. Curr Med Res Opin. 2013;29(5):579–588. doi:10.1185/03007995.2013.77250623368897
   PubMed Web of Science ®Google Scholar
• HuchonG, MagnussenH, ChuchalinA, DymekL, GonodFB, BousquetJ. Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir Med. 2009;103(1):41–49. doi:10.1016/j.rmed.2008.09.00218977646
   PubMed Web of Science ®Google Scholar
• JenkinsC, KolarikovaR, KunaP, et al. Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma. Respirology. 2006;11(3):276–286. doi:10.1111/j.1440-1843.2006.00856.x16635085
   PubMed Web of Science ®Google Scholar
• Van den BergNJ, OssipMS, HederosCA, AnttilaH, RibeiroBL, DaviesPI. Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (seretide) is effective and safe in children with asthma. Pediatr Pulmonol. 2000;30(2):97–105. doi:10.1002/1099-0496(200008)30:2<97::AID-PPUL4>3.0.CO;2-P10922131
   PubMed Web of Science ®Google Scholar
• ChapmanKR, RingdalN, BackerV, PalmqvistM, SaarelainenS, BriggsM. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers. Can Respir J. 1999;6(1):45–51. doi:10.1155/1999/89480310202220
   PubMedGoogle Scholar
• NoonanM, RosenwasserLJ, MartinP, O’BrienCD, O’DowdL. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. Drugs. 2006;66(17):2235–2254. doi:10.2165/00003495-200666170-0000617137405
   PubMed Web of Science ®Google Scholar
• PapiA, CanonicaGW, MaestrelliP, et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med. 2007;356(20):2040–2052. doi:10.1056/NEJMoa06386117507703
   PubMed Web of Science ®Google Scholar
• MohanA, GuleriaR, DasC, SharmaR. Comparison of the efficacy of inhaled ipratropium bromide and salbutamol sequentially and in fixed dose combination in patients with stable bronchial asthma. Chest. 2003;124(4):139S. doi:10.1378/chest.124.4_MeetingAbstracts.139S-a
   Web of Science ®Google Scholar
• KawaiM, KempsfordR, PulleritsT, et al. Comparison of the efficacy of salmeterol/fluticasone propionate combination in Japanese and Caucasian asthmatics. Respir Med. 2007;101(12):2488–2494. doi:10.1016/j.rmed.2007.07.00117900887
   PubMed Web of Science ®Google Scholar
• ChawesBL, PiccinnoA, Kreiner-MollerE, et al. Pharmacokinetic comparison of inhaled fixed combination vs. the free combination of beclomethasone and formoterol pMDIs in asthmatic children. Br J Clin Pharmacol. 2013;75(4):1081–1088. doi:10.1111/j.1365-2125.2012.04459.x22978252
   PubMed Web of Science ®Google Scholar
• HochhausG, KaiserK. Comparing the safety and efficacy of fluticasone/formoterol combination therapy in a single inhaler at low and medium doses, with fluticasone and formoterol concurrently or alone, in asthma patients. Allergy. 2011;66:585. doi:10.1111/j.1398-9995.2011.02683.x
   Web of Science ®Google Scholar
• MillerCJ, SennS, MezzanotteWS. Bronchodilation of formoterol administered with budesonide: device and formulation effects. Contemp Clin Trials. 2008;29(2):114–124. doi:10.1016/j.cct.2007.05.00817625985
   PubMed Web of Science ®Google Scholar
• SimpsonCR, Hippisley-CoxJ, SheikhA. Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51 804 patients. Br J Gen Pract. 2010;60(576):277–284. doi:10.3399/bjgp10X51472920594429
   PubMed Web of Science ®Google Scholar